1 | Male | Testis | EC | Congested (30%) F-RBC in blood lakes surrounding the tumour cells (fig 2A) | hCG and AFP negative |
2 | Male | Testis | EC | Positive as in 1. Also 2–5% F-RBC in blood vessels | No F-RBC in the counterpart normal testis |
3 | Male | Retroperitoneal lymph node | EC | Positive as in 2 | |
4 | Male | Testis | EC | None | hCG and AFP positive |
5 | Male | Brain | MMT | Congested (30%) F-RBC in blood lakes and haemorrhagic zones (fig 2B) in blood vessels 5% | hCG positive AFP negative |
6 | Female | Brain | MMT | Positive as in 5 | |
7 | Male | Retroperitoneal lymph node | MMT | None | |
8 | Male | Testis | MMT | none | |
9 | Female | Ovary | Mixed germinoma and YS | In germinoma positive as in 1. In YS none | AFP positive in YS. hCG negative |
10–14 | Male | Testis | NMT | None | |
15 | Male | Brain | Mixed seminoma and mature teratoma | None | |
16 | Female | Lymph node | Mixed YS and mature teratoma | None | AFP positive in YS |
17 | Female | Ovary | Dermoid cyst | Positive as in 2 | |
18–26 | Female | Ovary | Dermoid cyst | None | |